Combined cephalosporin aminoglycoside therapy in gram-negative sepsis. The choice of cephalosporin.
Mészáros
J
J
Department of Vascular Surgery and Transplantology, National Institute of Hygiene, Chocimska 24, 00-791 Warsaw, Poland.
Tołłoczko
T
T
Stachlewska
E
E
Tyc
Z
Z
Jeljaszewicz
J
J
D000328:Adult; D000368:Aged; D000617:Aminoglycosides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001421:Bacteria, Anaerobic / Q000302:isolation & purification; D002442:Ceftazidime / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D002442:Ceftazidime